NBT Technology

Ancon Medical has developed a revolutionary technology called Nanoparticle Biometric Tagging that gives medical professionals the capability to detect deadly diseases in a patient’s breath.

Disease Screening

No matter what the disease, early diagnosis gives medical personnel more opportunities for treatment. NBT technology offers powerful capabilities to screen for a wide range of diseases with unprecedented sensitivity.

Medical Alley

As a member of Medical Alley, the community of health industry leaders, Ancon Medical is committed to being a leader in the research and development of innovative healthcare technology.

Products

Ancon Medical has developed a revolutionary technology called Nanoparticle Biometric Tagging (also known as Nanoparticle Biomarker Tagging) NBT that provides medical professionals with the capability to detect deadly diseases in a patient’s breath. These biomarkers are the signature of a disease and discovering them can give doctors the ability to make an early diagnosis and begin potentially life-saving treatment.

ANCON-MEDICAL-INC in Times Square NYC

About Ancon

Focusing on the development of revolutionary, non-invasive disease screening technology, Ancon Medical Inc. is a medical device maker focusing on the development of revolutionary, non-invasive disease screening technology.

News and Articles

Ancon Medical presents unique solutions for the healthcare industry, providing a pathway to early detection capabilities that can be critical for treating deadly illnesses like lung cancer, tuberculosis and others. Read latest news and articles related to healthcare industry.

Latest News & Articles

Read all articles
November 21, 2018

Early Detection of a Silent Killer: Pancreatic Cancer

Pancreatic cancer is unpreventable and fast progressing, heightening the need for early diagnosis. ANCON hopes to improve the odds with the NBT.

Contact Us

  • UK –  01227 811705
  • USA – Please use contact form

NBT Technology Video